You are here

  • Home
  • Archive
  • Volume 6, Issue 12
  • Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol

Article metrics

Article menu

Download PDFPDF

XML
Rheumatology
Protocol
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 2018474712
Feb 2018555011
Mar 2018676519
Apr 2018292815
May 2018515122
Jun 2018222210
Jul 2018464614
Aug 2018282813
Sep 2018252513
Oct 2018353525
Nov 2018252514
Dec 2018252515
Jan 2019282811
Feb 2019262614
Mar 2019181821
Apr 2019302629
May 2019212119
Jun 2019222211
Jul 2019292913
Aug 201914149
Oct 2019212223
Nov 2019191713
Dec 2019212119
Jan 2020171715
Feb 2020101012
Mar 2020181610
May 202019198
Jun 2020313051
Jul 2020332316
Aug 2020222214
Sep 202025197
Oct 2020353414
Nov 202027249
Dec 202029223
Jan 2021252412
Feb 2021151410
Mar 202125259
Apr 2021293014
May 2021444412
Jun 202117175
Jul 2021495233
Aug 2021121110
Sep 2021403823
Oct 2021353528
Nov 2021242421
Dec 202127277
Jan 2022464412
Feb 2022282813
Mar 2022827410
Apr 2022323219
May 2022353414
Jun 2022403411
Jul 202220209
Aug 202230258
Sep 2022322417
Oct 2022514911
Nov 202237279
Dec 202225218
Jan 202323177
Feb 202330248
Mar 2023422814
Apr 2023292319
May 2023262112
Jun 202319133
Jul 2023191916
Aug 2023191714
Sep 2023251510
Oct 202325209
Nov 2023372711
Dec 2023343216
Jan 2024353515
Feb 2024282210
Mar 2024434136
Apr 2024222119
Total222620551068